Tybourne Capital Management Investor

Tybourne is a global investment firm with a fundamental approach to equity investing, both public and private


Invests into

Industry: Longevity Biomarkers
Acquisitions Number: 4
Number Of Exists: 7
Headquarters: Hong Kong, Hong Kong Island, Hong Kong
Investor Type: Hedge Fund, Private Equity Firm
Employee Number: 11-50
Investors Number: 21
Investment Stage: Late Stage Venture, Post-Ipo, Private Equity
Founded Date: 2011-01-01